THC Pharm GmbH has been producing and distributing Dronabinol, the analgesic and antispasmodic pure active ingredient of the cannabis plant, since 1998. Despite rapid growth over the last years the substance is classified as a prescribable narcotic, we have been holding on to our roots as a patient-based initiative and have been looking for new ways of developing herbal-based effective substances and base agents.

The formulation substance, which we developed in a unique process, is subject to German narcotics law. Therefore, please understand that large parts of our newly revised homepage are password protected and information about effectiveness, areas of therapeutic application, prescription and production can only be made accessible to doctors and pharmacists.

For further general information on the medical use of cannabis, we recommend the following homepage “Arbeitskreis Cannabis in der Medizin (ACM)” on which more valuable information and links have been gathered. www.cannabis-med.org